This site is intended for healthcare professionals only


Transcending the template: strategies for optimising complex patient management was an interactive CME symposium on the occasion of the 52nd Annual Meeting of the European Association for the Study of Diabetes

EASD16_logo Co-Chairs: Professor Silvio Inzucchi and Professor David Matthews
Date/Time: Monday 12 September 2016, 13:30–16:00
Congress: 52nd EASD Annual Meeting 2016


The programme’s key aim is to provide the audience with expert insight into how to optimise treatment strategies for patients.

Learning objectives

After this symposium, attendees will be able to:

  • Identify and optimise treatment targets for individual patients using the most recent practice guidelines for diabetes and related conditions (e.g. obesity, heart disease)
  • Determine appropriate pharmacologic strategies for patients with diabetes and the rationale for selection of specific therapeutic classes and drug combinations
  • Discuss management of difficult-to-treat patients with complex comorbidities and other conditions that fall outside of standard practice guidelines
  • Apply current recommendations for escalation of diabetes therapies in cases of disease worsening or treatment failure


Time Title Speaker
13:30-13:40 Chairs’ welcome Prof David Matthews
13:40-13:55 Setting targets and optimising strategies in complex patients Prof Silvio Inzucchi
13:55-14:25 Interactive patient case study: heart failure and coronary artery disease Dr Mikhail Kosiborod
14:25-14:55 Interactive patient case study: severe obesity Prof Rachel Batterham
14:55-15:45 Interactive patient case study: advanced microvascular disease Prof Roland Schmieder
Prof Dr Hans-Peter Hammes
15:45-16:00 Chairs’ summary Prof David Matthews

Who is this suitable for?

Do you have an interest or a role in diabetes management? If so, this symposium is for you. Endocrinologists, diabetologists, GPs, diabetes nurses and any other healthcare professional with an interest or role in diabetes patient management are all welcome.